| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr7_0010300 | Intergenic-Intergenic | chr7:100417847-100421398 | chr7:100820225-100823776 | 602 nt | 0.6561 |
| hsa_EPHB4_0003100 | Exon-Exon | chr7:100419893-100421291 | chr7:100822271-100823669 | 26 nt | 0.5385 |
| hsa_chr7_0010400 | Intergenic-Intergenic | chr7:100420250-100421347 | chr7:100822628-100823725 | 122 nt | 0.6393 |
| hsa_chr7_0010500 | Intergenic-Intergenic | chr7:100421276-100421506 | chr7:100823654-100823884 | 231 nt | 0.6753 |
| hsa_chr7_0010600 | Intergenic-Intergenic | chr7:100421348-100421891 | chr7:100823726-100824269 | 206 nt | 0.6845 |
| hsa_EPHB4_0003200 | Exon-Exon | chr7:100424601-100424925 | chr7:100826979-100827303 | 325 nt | 0.7538 |
A study in mice demonstrated that the circEPHB4 inhibits hepatocellular carcinoma progression by regulating HIF-1α and PI3K-AKT pathways [Huang et al. DOI:10.3390/cells11091381].